Table 1 The characteristics of the total patient group
Demographic features (n = 174) | |
|---|---|
Sex (F/M) (n, %) | 128/46 (73.6/26.4) |
Age, mean ± SD, min–max | 45.2 ± 13.3 (18–81) |
Mig-SCog, mean ± SD | 5.73 ± 4.90 |
Patients with a comorbid systemic disease (n, %) | 116 (66.7) |
Pre-existing headache history (n, %) | 107 (61.5) |
-Pre-existing headache types (n, %) | |
–Migraine | 85 (79.4) |
–Tension-type headache | 13 (12.1) |
–Trigeminal autonomic headache | 2 (1.9) |
–Migraine + Medication overuse headache | 2 (1.9) |
–Other primary headache types | 5 (4.7) |
COVID-19 history at the referral (n, %) | 80 (46) |
Presence of headache in patients with COVID-19 history (n, %) | 51 (63.7) |
Other long COVID symptoms (among patients with COVID-19 history) (n, %) | |
-Fatigue | 55 (68.8) |
-Cognitive involvement | 36 (45) |
-Psychiatric symptoms | 9 (11.3) |
-Sleep disorders | 22 (27.5) |
-Hair loss | 23 (29.1) |
Secondary headache diagnosis related to COVID-19 vaccination | 8 (4.6) |